TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Premeon Pharma Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
252
|
2
|
4 |
| Financial expenses | 0 | ||
| Earnings before taxes |
-1
|
14
|
0 |
| Total assets |
424
|
56
|
7 |
| Current assets |
65
|
30
|
6 |
| Current liabilities |
409
|
39
|
4 |
| Equity capital |
16
|
17
|
3 |
| - share capital |
3
|
3
|
3 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
3.8%
|
30.4%
|
42.9% |
| Turnover per employee |
252
|
2
|
4 |
| Profit as a percentage of turnover |
-0.4%
|
700%
|
0% |
| Return on assets (ROA) | 25.0% | ||
| Current ratio |
15.9%
|
76.9%
|
150.0% |
| Return on equity (ROE) |
-6.2%
|
82.4%
|
0% |
| Change turnover |
250
|
-2 | |
| Change turnover % |
12500%
|
-50% | |
| Chg. No. of employees |
0
|
0 | |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.